LCTX
Lineage Cell Therapeutics Inc
0.9274$
-0.3%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -2,797.5% | – | – | |
| – | – | – | – | +26.7% | +291.7% | +71.4% | +60.0% | +29.4% | -99.4% | +315.9% | -813.8% | – | +106.6% | +2,585.0% | +154.8% | +19.7% | +39.5% | +112.8% | -24.7% | -24.9% | -30.7% | -0.7% | -8.3% | -32.0% | -57.2% | -16.7% | -4.8% | -12.0% | +14.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | -11.0% | +263.2% | +30.7% | +90.6% | +5.3% | +150.9% | +38.5% | +148.0% | -28.0% | -50.5% | +37.4% | -33.7% | -37.8% | +58.0% | +21.8% | +8.2% | +9.4% | -6.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +41.2% | – | – | – | |
| – | – | -93.3% | +340.4% | -157.0% | – | – | +69.5% | +180.6% | +37.3% | -44.5% | -60.3% | +1,248.6% | -121.2% | – | – | +1,691.6% | +482.4% | -130.3% | – | -122.4% | – | -74.3% | -406.6% | – | +1,437.5% | -11.6% | -157.9% | – | – | |
| – | – | +0.0% | +61.7% | -79.3% | -84.7% | -25.1% | -100.0% | – | – | – | -39.3% | +13,184.0% | -92.9% | +611.2% | +120.7% | -58.3% | +468.1% | -78.8% | +1,004.1% | -52.6% | -47.5% | +147.9% | -86.6% | -85.5% | +453.1% | +16.7% | +63.2% | -16.2% | -7.6% | |
| – | – | – | +61.7% | -79.3% | -84.7% | -25.1% | – | – | – | – | -39.3% | +13,956.4% | -94.9% | – | -137.6% | -91.3% | +3,401.5% | -72.5% | +638.3% | +46.3% | -6.1% | – | +43.5% | -23.1% | -25.3% | -573.7% | – | -105.0% | +483.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +7,479.1% | -99.9% | +62,767.5% | -71.2% | – | – | – | – | |
| – | +0.0% | +0.0% | -36.0% | -71.7% | – | – | – | – | +133.9% | – | – | – | – | – | – | – | – | +81.0% | -21.6% | -33.7% | -102.7% | -72.9% | -54.4% | -75.5% | +100.0% | -68.5% | +117.6% | -37.8% | -30.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -45.8% | +532.2% | -89.3% | -302.9% | -79.9% | – | -100.1% | +60.0% | +68.8% | +0.0% | +9.3% | |
| – | +509.1% | -94.0% | +1,755.1% | -87.7% | +287.5% | -50.3% | -95.1% | +2,420.6% | -14.3% | -100.0% | +551,437.3% | +262.2% | +554.9% | +56.3% | -85.0% | -50.5% | +1,690.7% | +85.7% | +1.8% | -49.4% | +69.0% | -89.6% | -89.3% | +4,740.4% | +23.7% | -95.6% | +293.6% | +458.3% | -24.8% | |
| – | – | -131.5% | – | -238.8% | – | -210.1% | – | – | -29.2% | -374.9% | – | – | +438,229.8% | +73.6% | -152.6% | – | – | +1,994.4% | -46.9% | -258.1% | – | -190.1% | – | – | +0.0% | -292.0% | – | -56.9% | -148.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -4,626.3% | – | – |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.